Noyavision also focus on developing flexible and strong collaborations with a wide range of partners to strengthen its own capabilities.
Noyavision’s well established business structure, talented human resources, history and reputation, knowledge of the market and market penetration, infrastructure and facility can integrate successfully with our future partners who have common vision and complementary strength.
Our Business Development team is structured to ensure we have the right expertise to identify, evaluate and transact on the right opportunities. Our Business Development team bring deep science, development and business expertise and work closely with R&D and commercial leaders to source external innovation that will augment our internal line.
Introduction
Today Noyavision is a fully integrated company in pharmaceutical and nutraceutical business. We’re ready to provide customized solutions for our partners that span the entire value chain, from value definition and market analysis to registration, sales and marketing and pharmacovigilance.
Noyavision is currently started to engage in several collaborations with a number of leading companies and continuously looks to extend its number of partnerships in the future. Our strong experience combined with a successful track record of accomplishments, offers a unique opportunity to partners interested in pursuing expanding their operation and sales in one of Middle East biggest pharmaceutical markets.
Regulatory
In Regulatory Affairs we obtain the licenses needed to bring high quality therapies to patients and caregivers in Iran where Noyavision operates.
The role of Regulatory Affairs continues throughout the lifetime of a medicine and consumer healthcare product, with involvement in advertising, labelling and the monitoring of safety.
In Noyavision’s regulatory affairs we engage in close dialogue with our Health Authority which is Iran Food & Drug Administration (IFDA) to secure favorable, sound and informed decision-making in all phases of registration process – for the benefits of the patients.
We strive to be responsive to business needs of ourselves and our partner’s corporate, and to minimize time to marketing authorization while ensuring compliance in a changing regulatory environment. This is accomplished via forming specialized teams for imported, in-licensed and locally manufactured medicine and dietary supplements, supervised by their own team leader and qualified pharmacist.
Regulatory Affairs had several milestones by solving bottleneck issues with the IFDA including fast track registration of certain products, introducing new molecular entities to Iran pharmacopeia, brand product registration, skipping many site audits and managing document discrepancies and deficiencies.
We have a distinct and decisive approach to partnering that leverages the best of Noyavision and the best of our partners to speed transformational medicines to patients. We strive to be a partner of choice and establish a creative and customized approach for each agreement.
All production take place in best plants which meets all GMP and GLP requirements.
Operations are continually being developed through technological investments and automation and are carried out employing production management system applications within closed systems, which increase traceability and efficiency.